EW vs. MCK
EW (Edwards Lifesciences Corporation) and MCK (McKesson Corporation) are both stocks. Both are in the Healthcare sector — EW in Medical Devices, MCK in Medical Distribution. Over the past 10 years, EW returned 9.98%/yr vs 15.61%/yr for MCK. At a 0.28 correlation, their price movements are largely independent.
Performance
EW vs. MCK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EW achieves a 2.83% return, which is significantly higher than MCK's -10.01% return. Over the past 10 years, EW has underperformed MCK with an annualized return of 9.98%, while MCK has yielded a comparatively higher 15.61% annualized return.
EW
- 1D
- -0.57%
- 1M
- 4.38%
- YTD
- 2.83%
- 6M
- 3.48%
- 1Y
- 12.24%
- 3Y*
- 0.90%
- 5Y*
- -1.46%
- 10Y*
- 9.98%
MCK
- 1D
- 0.27%
- 1M
- -9.39%
- YTD
- -10.01%
- 6M
- -11.03%
- 1Y
- 2.50%
- 3Y*
- 24.17%
- 5Y*
- 31.32%
- 10Y*
- 15.61%
EW vs. MCK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | 2.83% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 52.31% | 35.90% | 20.29% |
MCK McKesson Corporation | -10.01% | 44.54% | 23.67% | 24.13% | 51.82% | 44.23% | 27.06% | 26.72% | -28.40% | 11.95% |
Correlation
The correlation between EW and MCK is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Mar 28, 2000 | 0.28 |
The correlation between EW and MCK shifts across timeframes, from 0.14 (3 years) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
EW:
$50.90B
MCK:
$90.40B
EW:
$1.87
MCK:
$38.38
EW:
46.85
MCK:
19.20
EW:
1.51
MCK:
0.26
EW:
8.12
MCK:
0.23
EW:
4.93
MCK:
13.07
EW:
$6.30B
MCK:
$403.43B
EW:
$4.92B
MCK:
$14.55B
EW:
$1.44B
MCK:
$6.91B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EW vs. MCK — Risk / Return Rank
EW
MCK
EW vs. MCK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and McKesson Corporation (MCK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EW | MCK | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.52 | 0.09 | +0.43 |
Sortino ratioReturn per unit of downside risk | 0.94 | 0.36 | +0.59 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.05 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 0.95 | 0.11 | +0.84 |
Martin ratioReturn relative to average drawdown | 2.33 | 0.30 | +2.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EW | MCK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.52 | 0.09 | +0.43 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.04 | 1.30 | -1.35 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.31 | 0.54 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.44 | +0.08 |
Drawdowns
EW vs. MCK - Drawdown Comparison
The maximum EW drawdown since its inception was -54.32%, smaller than the maximum MCK drawdown of -82.84%. Use the drawdown chart below to compare losses from any high point for EW and MCK.
Loading charts...
Drawdown Indicators
| EW | MCK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.32% | -82.84% | +28.52% |
Max Drawdown (1Y)Largest decline over 1 year | -12.73% | -27.17% | +14.44% |
Max Drawdown (3Y)Largest decline over 3 years | -37.53% | -27.17% | -10.36% |
Max Drawdown (5Y)Largest decline over 5 years | -54.32% | -27.17% | -27.15% |
Max Drawdown (10Y)Largest decline over 10 years | -54.32% | -44.23% | -10.09% |
Current DrawdownCurrent decline from peak | -32.92% | -25.92% | -7.00% |
Average DrawdownAverage peak-to-trough decline | -14.46% | -28.65% | +14.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.19% | 9.61% | -4.42% |
Volatility
EW vs. MCK - Volatility Comparison
The current volatility for Edwards Lifesciences Corporation (EW) is 8.07%, while McKesson Corporation (MCK) has a volatility of 9.57%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than MCK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EW | MCK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.07% | 9.57% | -1.50% |
Volatility (6M)Calculated over the trailing 6-month period | 18.68% | 23.04% | -4.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.84% | 28.92% | -5.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.60% | 24.17% | +8.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.24% | 28.81% | +3.43% |
Dividends
EW vs. MCK - Dividend Comparison
EW has not paid dividends to shareholders, while MCK's dividend yield for the trailing twelve months is around 0.45%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MCK McKesson Corporation | 0.45% | 0.37% | 0.47% | 0.50% | 0.54% | 0.72% | 0.95% | 1.16% | 1.32% | 0.80% | 0.80% | 0.53% |
Financials
EW vs. MCK - Financials Comparison
This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and McKesson Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EW vs. MCK - Profitability Comparison
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.
MCK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, McKesson Corporation reported a gross profit of 4.04B and revenue of 96.30B. Therefore, the gross margin over that period was 4.2%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.
MCK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, McKesson Corporation reported an operating income of 2.09B and revenue of 96.30B, resulting in an operating margin of 2.2%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.
MCK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, McKesson Corporation reported a net income of 1.68B and revenue of 96.30B, resulting in a net margin of 1.8%.
Frequently Asked Questions
EW and MCK have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MCK has higher volatility (9.57%) compared to EW (8.07%). In terms of maximum drawdown, EW dropped -54.32% vs MCK's -82.84%.
EW currently has the higher Sharpe Ratio (0.52 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EW and MCK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer